FOKUS Patient turns international

FOKUS Patient is arranging conferences over 3 days in October, and this year, the focus will be on international collaborations.

Founder of Bioarctic, Lars Lannfelt, is honoured: “I want to create something for the future”

It´s like a scientist’s dream: to be the world’s first with a drug that genuinely affects one of our major diseases. Lars Lannfelt and his company Bioarctic hav...

Trends and overview: ELRIG "Robotics and Automation"

Laboratories on the way to end-to-end automation: Robotics, artificial intelligence and automation technology boosted by pandemic

Festo Expands its Portfolio with Multilayer Manifolds

Manufacturers of medical and laboratory equipment now receive solutions from a single source

RegFile AB

Immedica tar över epilepsiläkemedel i miljardaffär

Stockholmsbaserade Immedica Pharma har ingått ett avtal om att förvärva amerikanska Marinus Pharmaceuticals för cirka 151 miljoner dollar, motsvarande nästan 1,...

Peptonic drar sig ur Israel – "Ökade svårigheter"

Peptonic Medical har beslutat att avveckla sitt israeliska dotterbolag på grund av ”lönsamhetsutmaningar” och ”ökade svårigheter att bedriva verksamhet” i landet.

Obesity-drug pioneers win Lasker Award

This year’s Lasker Prize in Clinical Research has been awarded to three researchers for their discoveries in GLP-1-based drugs that, according to the jury, “hav...

The impact of the recession on the Swedish medtech sector

We need health care regardless of whether the economy is good or bad, but the current recession also affects the Medtech sector.

About Microscope Ergonomics

Learn about ergonomic microscope design and how you can increase your well-being and productivity when working in clinical microscopy. Read about challenges, de...

“Everyone is screaming for talent”

Attracting talent is one of the life science industry’s major future challenges, which was one of the conclusions of the panel discussion that ended the New Hor...

Björn Arvidsson: “We need robust and recognized ecosystems for continued competitiveness”

“We have idea carriers and excellent innovation opportunities, and now we must invest in creating ecosystems that provide them with even better growth opportuni...

Swedish-Danish meeting at Medicon Village: “One of the most important life science congresses”

For the eleventh year, The Future of Swedish and Danish Life Science was held on Wednesday, and the event continues to function as a connecting link between the...

Efter motgångar – framsteg för Oncopeptides i Italien

Knappt ett år efter bakslaget i USA får Oncopeptides nu medvind i Europa. Det svenska bolaget får ett formellt godkännande för full subvention av sitt cancerläk...

Hajpat genterapibolag skär ner med 65 procent

Det en gång så omsusade genterapibolaget Editas Medicine säger upp 65 procent av sin personal – omkring 180 medarbetare – till följd av ett beslut om att avbryt...

On the hunt for high throughput diagnostics

Global diagnostics companies and laboratories are in a race against time to adapt testing capacity to current demand. Due to the global COVID 19 pandemic, the d...

Sobi announces agreement with Enable Injections

Swedish biopharma Sobi has entered into an international development and distribution agreement with US drug delivery company Enable Injections.

Cancer researcher: “We can do better and reduce suffering”

Lund University researcher Catharina Hagerling is developing innovative methods to understand metastatic cancer, aiming to create more targeted treatments for p...

Biosimilars bring price pressure, but are they sufficiently used?

When biosimilars were introduced just over 16 years ago, hopes were raised that they would give many more patients access to effective but otherwise extremely e...

ProPharma

CTC Clinical Trial Consultants AB

GSK acquires oncology research company

GSK acquires the American biotechnology company Idrx for up to 1.15 billion dollars.

Tougher competition as the Novo Nordisk Foundation broadens its programme

Søren Nedergaard has worked with innovation at the Danish Government Offices and the University of Copenhagen. Today, he is COO of the Novo Nordisk Foundation, ...

Hon ska leda affärsutvecklingen på Diamyd i Umeå

Diamyd Medical, som utvecklar läkemedel mot typ 1-diabetes, har anställt Sofia Mayans som affärsutvecklingschef vid företagets produktionsanläggning i Umeå.